Results 161 to 170 of about 1,744 (184)

Assessment of pharmacokinetics-pharmacodynamics to support omadacycline dosing regimens for the treatment of patients with acute bacterial skin and skin structure infections. [PDF]

Antimicrob Agents Chemother
Bhavnani SM, Hammel JP, Lakota EA, Liolios K, Trang M, Rubino CM, Steenbergen JN, Friedrich L, Tzanis E, Ambrose PG.   +9 more
europepmc   +1 more source

Real-World Use of Dalbavancin in a United States Tertiary Referral Center. [PDF]

Cureus
Polega J, Bhugra M, Vanderhorst D, de Sanctis J, Chang A, Hassouna H.   +5 more
europepmc   +1 more source

Off-label use of dalbavancin in children: a case series. [PDF]

J Antimicrob Chemother
Gamell A, Velasco-Arnaiz E, López-Ramos MG, Ríos-Barnés M, Simó-Nebot S, Fumadó V, Noguera-Julián A, Fortuny C.   +7 more
europepmc   +1 more source

Use of Dalbavancin in Treatment of Acute Bacterial Skin and Skin Structure Infections: Case Series from a Canadian Perspective. [PDF]

J Assoc Med Microbiol Infect Dis Can
Leung W, Bhalla J, Ataie L, Elsayed S, Bondy L, Devlin M, Shalhoub S, Saeed H, Mohammadi M, Silverman M, Shahmirzadi RR.   +10 more
europepmc   +1 more source

Comparative in vitro activity of Delafloxacin and other antimicrobials against isolates from patients with acute bacterial skin, skin-structure infection and osteomyelitis. [PDF]

Braz J Infect Dis
Ribeiro ÁCDS, Santos FF, Valiatti TB, Lenzi MH, Santos INM, Neves RFB, Moses IB, Meneses JP, Di Sessa RGG, Salles MJ, Gales AC.   +10 more
europepmc   +1 more source

Evaluation of Ceftaroline Use in Pediatric Patients: A Retrospective Case Series. [PDF]

Antibiotics (Basel)
Miller A, Grizzle M, Van Poppel H, Alvira-Arill GR, Lueking R, Thacker SA, Hornback KM, Morrisette T.   +7 more
europepmc   +1 more source

Fever for days: A challenging case of dalbavancin-induced fever. [PDF]

IDCases
Almahal MA, Wan C, Albrecht B, Green S, Babiker A.   +4 more
europepmc   +1 more source